AIR2 study information

Artimis®: the new name for the world’s first artificial meniscus

As the first company worldwide, ATRO Medical will start a clinical trial on a lateral artificial meniscus. For the first time ever, an absent meniscus in the outer part of the knee will be replaced by an artificial meniscus, the Artimis® Meniscus Prosthesis. The study will be conducted at the Radboud University Medical Center in Nijmegen.

This clinical study is initiated in October 2021 to enroll 14 patients at select medical centers in the Netherlands. The study is full and can no longer accept new participants. The clinical study is approved by the Dutch government (Dutch Health and Youth Care Inspectorate) and Medical Research Ethics Committee.

The Orthopaedic Research Laboratory (ORL) of Radboudumc starts a new project with ATRO Medical: 3D-Printed PCU meniscus Prosthesis (3PPP). 3PPP combines the latest developments in sports medicine with the strength of AI. The durable meniscus prosthesis of ATRO Medical will be designed in 3D based on artificial intelligence, developed by the Orthopaedic Research Lab. Thanks to this technology, a scan of the healthy meniscus in one leg can be used to create a meniscus solution for the affected leg. In this way, the side with a lacking meniscus causing severe knee pain can receive a new shock absorber, molded to the individual patient.

Introduction to ATRO Medical

Dutch medical innovations are rarely granted the Breakthrough Designation by the FDA. Startup ATRO Medical from Nijmegen is the new kid on the block in orthopedics. This week their Trammpolin® meniscus prosthesis (nowadays known as Artimis®), designed to treat chronic knee pain, received the Breakthrough Device Designation from the FDA. The designation demonstrates the innovation potential of this implant and expedites US market access by receiving a priority treatment at the FDA.

An international consortium led by the Dutch med-tech startup ATRO Medical receives over € 800,000 EUROSTARS funding to address an unmet need for Knee Osteoarthritis patients. These patients often suffer from cartilage degradation related to a dysfunctional meniscus. Based on previous research, the consortium will develop a durable meniscus prosthesis for the outer knee compartment to relief pain and restore mobility. This would change the life of thousands of osteoarthritis patients.

Yess!! ATRO Medical has been named an Awardee in the Veterans Lead QuickFire Challenge organized by Johnson & Johnson Innovation!

Orthopedic startup ATRO Medical enters a partnership together with the Dutch Arthritis Society for further development of the artificial meniscus. The Dutch startup works on a meniscus prosthesis for people with knee arthritis. The Dutch Arthritis Society supports these developments and shares its experience as patient expert in the field of arthritis. 

The European Commission grants € 2.5 million to ATRO Medical for the accelerated development of their artificial meniscus. The Dutch startup works on the first anatomical meniscus prostheses for patients with chronic knee pain. Their ground-breaking innovation continues to attract international attention, paving the way towards full-scale healthcare implementation.